Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are currently pregnant or were recently pregnant
- People who have been diagnosed with ulcerative colitis (UC), a type of inflammatory bowel disease
- People living in a country where the medication ozanimod has been approved and prescribed for the treatment of ulcerative colitis
Who may not be able to join:
- People who were exposed to other medications in the same drug class as ozanimod (called S1P therapies) at any point during their pregnancy
Important: Other eligibility requirements set out in the trial protocol may also apply. Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Event rate of Major Congenital Malformations (MCM)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.